MedTrace Logo

Immunological Characteristics of Patients With PID and IBD

NCT03148028 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2017-05-10

No results posted yet for this study

Summary

The investigators wish to characterize alterations in the architecture and function of immune cells in patients with a primary immunodeficiency that also develop inflammatory bowel disease. In addition, The investigators' goal is to characterize the microbiome of these patients, in order to determine whether specific microbial alterations are related to inflammation.

Conditions

  • Inflammatory Bowel Diseases
  • Primary Immune Deficiency Disorder

Sponsors & Collaborators

  • Sheba Medical Center

    lead OTHER_GOV

Principal Investigators

  • Dror S Shouval, MD · Edmond and Lily Safra Children's Hospital

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-15
Primary Completion
2020-06-01
Completion
2020-12-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03148028 on ClinicalTrials.gov